From: Health Data Management
The Food and Drug Administration’s policies and procedures are not sufficient for effectively dealing with postmarket medical device cybersecurity events, an emerging risk to public health and the FDA’s mission.
That’s the finding of an audit by the Department of Health and Human Services’ Office of Inspector General.
Leave a Reply